Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
X-ray repair cross complementing 3 | 0.505 | 0.769 | 1.9E-10 |
|
disease | 0.360 | None | 0.500 | 1 | 0 | 2000 | 2016 | ||||||||
|
colony stimulating factor 3 | 0.377 | 0.885 | 0.38 |
|
disease | 0.330 | None | 0.600 | 2 | 0 | 1987 | 2015 | ||||||||
|
syntaxin 17 | 0.792 | 0.308 | 9.5E-05 |
|
disease | 0.320 | None | 0.667 | 1 | 0 | 2008 | 2014 | ||||||||
|
protein tyrosine kinase 2 beta | 0.448 | 0.808 | 0.94 |
|
disease | 0.340 | None | 0.750 | 1 | 0 | 2002 | 2017 | ||||||||
|
ERCC excision repair 1, endonuclease non-catalytic subunit | 0.445 | 0.846 | 1.6E-07 |
|
disease | 0.350 | None | 0.800 | 1 | 0 | 2007 | 2018 | ||||||||
|
FTO alpha-ketoglutarate dependent dioxygenase | 0.486 | 0.885 | 8.4E-08 |
|
disease | 0.440 | None | 0.800 | 1 | 0 | 2013 | 2019 | ||||||||
|
protection of telomeres 1 | 0.560 | 0.731 | 0.85 |
|
disease | 0.470 | None | 0.857 | 1 | 0 | 2011 | 2019 | ||||||||
|
MAGE family member A1 | 0.601 | 0.462 |
|
disease | 0.400 | None | 0.903 | 1 | 0 | 1991 | 2017 | |||||||||
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
disease | 0.400 | None | 0.917 | 2 | 0 | 2002 | 2019 | ||||||||
|
erb-b2 receptor tyrosine kinase 4 | 0.455 | 0.846 | 1.00 |
|
disease | 0.700 | None | 0.917 | 1 | 0 | 2009 | 2018 | ||||||||
|
fms related receptor tyrosine kinase 1 | 0.419 | 0.846 | 1.00 |
|
disease | 0.400 | None | 0.917 | 1 | 0 | 2000 | 2020 | ||||||||
|
galectin 3 | 0.392 | 0.846 | 2.3E-05 |
|
disease | 0.400 | None | 0.929 | 1 | 0 | 2003 | 2019 | ||||||||
|
S100 calcium binding protein A4 | 0.448 | 0.769 | 6.2E-03 |
|
disease | 0.400 | None | 0.929 | 1 | 0 | 1995 | 2018 | ||||||||
|
heparanase | 0.425 | 0.808 | 2.3E-14 |
|
disease | 0.400 | None | 0.929 | 1 | 0 | 1999 | 2015 | ||||||||
|
melanotransferrin | 0.663 | 0.500 | 1.2E-16 |
|
disease | 0.400 | None | 0.929 | 1 | 0 | 1986 | 2009 | ||||||||
|
cyclin dependent kinase 2 | 0.456 | 0.692 | 0.61 |
|
disease | 0.400 | None | 0.941 | 1 | 0 | 1994 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.700 | None | 0.943 | 4 | 0 | 1991 | 2020 | ||||||||
|
cytotoxic T-lymphocyte associated protein 4 | 0.369 | 0.923 | 0.94 |
|
disease | 0.400 | None | 0.946 | 1 | 0 | 2008 | 2020 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 0.800 | strong | 0.950 | 3 | 0 | 1997 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.800 | strong | 0.950 | 2 | 0 | 1994 | 2020 | ||||||||
|
solute carrier family 45 member 2 | 0.626 | 0.538 | 1.7E-06 |
|
disease | 0.500 | None | 0.950 | 2 | 0 | 1996 | 2019 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
disease | 0.400 | None | 0.952 | 1 | 0 | 2007 | 2018 | ||||||||
|
interferon alpha 1 | 0.371 | 0.923 |
|
disease | 0.400 | None | 0.958 | 7 | 0 | 1984 | 2019 | |||||||||
|
melanocortin 1 receptor | 0.524 | 0.808 | 8.1E-11 |
|
disease | 0.500 | None | 0.959 | 3 | 0 | 1996 | 2020 | ||||||||
|
G protein subunit alpha q | 0.516 | 0.808 | 0.98 |
|
disease | 0.700 | None | 0.967 | 1 | 0 | 1989 | 2019 |